T-DX
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for T-DX, covering 2023-05-12 to 2023-05-12. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of T-DX in HER2-positive Breast Cancer Brain Metastases [Phase 2]